The Motley Fool··Prosper Junior BakinyOral Weight-Loss Drug Expands Market Rather Than Cannibalizing Sales
Oral weight-loss drugs expand the market rather than cannibalizing injectables, attracting new patients. However, Novo Nordisk expects 2026 revenue headwinds from competition and pricing pressures.
LLYNVOGLP-1 drugspharmaceutical competition